NDC 63323-472-03 - SENSORCAINE MPF
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 63323-472
- Requested NDC
- 63323-472-03
- Package NDCs from labels
- 63323-472-03, 63323-472-17, 63323-472-01, 63323-472-37
- Manufacturer
- Fresenius Kabi USA, LLC
- Effective date
- 2023-04-30
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| SENSORCAINE MPF - Fresenius Kabi USA, LLC | Fresenius Kabi USA, LLC | 2023-04-30 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63323-472-01 | SENSORCAINEMPF | 30 mL in 1 VIAL, SINGLE-DOSE | INJECTION, SOLUTION | 30 | 7 | |
| 63323-472-03 | SENSORCAINEMPF | 10 mL in 1 VIAL, SINGLE-DOSE | INJECTION, SOLUTION | 10 | 7 | |
| 63323-472-17 | SENSORCAINEMPF | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 7 | |
| 63323-472-37 | SENSORCAINEMPF | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 7 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 63323-472 | SENSORCAINE MPF (BUPIVACAINE HYDROCHLORIDE) INJECTION, SOLUTION SENSORCAINE (BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC ] | 7 | Current NDC, Legacy NDC, 4 package rows | 20230712_bc61a9a6-0a4e-48a9-b908-e5e66b9f23eb.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 63323-472-01 | ML - Milliliter | 63323-472 | c80ec71b-5e22-4442-bfa7-680a2d9a2729 | 1 | 2022-12-07 |
| 63323-472-03 | ML - Milliliter | 63323-472 | d55b90ab-f67f-4735-a7bd-1e58502f1960 | 1 | 2022-04-06 |
| 63323-472-17 | ML - Milliliter | 63323-472 | eb8b4441-a708-44a0-895b-fc23777d15b8 | 1 | 2012-07-24 |
| 63323-472-33 | ML - Milliliter | 63323-472 | 56027130-de10-4c49-bef2-bf2b3f4ba0d1 | 1 | 2012-07-24 |
| 63323-472-37 | ML - Milliliter | 63323-472 | 5c74ff5f-2fe8-4015-ab09-1bf688f1f680 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Bupivacaine Hydrochloride | BUPIVACAINE HYDROCHLORIDE | Henry Schein, Inc | 3c0f567f-b7f8-4ee8-bfb2-61cd82550498 | 2026-10-26 | Boxed warning, Warnings, Adverse reactions | 7TQO7W3VT8 |
| Marcaine | BUPIVACAINE HYDROCHLORIDE | Hospira, Inc. | 67578b56-7540-487e-1fba-481255620e78 | 2026-10-23 | Boxed warning, Warnings, Adverse reactions | 1012384 1724787 1867596 1012377 1867594 1724786 30Q7KI53AK 7TQO7W3VT8 |
| Saline | NASAL | PUBLIX SUPER MARKETS, INC | 19841567-9511-43d6-ba4e-d1e1bd3481a4 | 2026-10-22 | Warnings | 451W47IQ8X |
| epinephrine | EPINEPHRINE | Baxter Healthcare Corporation | 60efd409-3555-4182-a68d-1cd7bc0d1bfc | 2026-10-19 | Warnings, Adverse reactions | 30Q7KI53AK |
| AQUACETIC-30 | CLEANING SOLUTION FOR HEMODIALYSIS MACHINES | Aqua Medica, S.A. de C.V. | 040775ab-41bd-cd36-e063-6394a90a08aa | 2026-10-16 | Warnings | 2968PHW8QP |
| CITRACID-50 | DESINFECTANT SOLUTION FOR HEMODIALYSIS MACHINE | Aqua Medica, S.A. de C.V. | 040713e7-67cd-8eb0-e063-6394a90aa2a9 | 2026-10-16 | Warnings | 2968PHW8QP |
| Isolyte S pH 7.4 | SODIUM CHLORIDE, SODIUM GLUCONATE, SODIUM ACETATE, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE, SODIUM PHOSPHATE, DIBASIC, AND POTASSIUM PHOSPHATE | B. Braun Medical Inc. | 150437b6-320e-4c69-a434-2a26a1f0b2e4 | 2026-10-12 | Warnings, Adverse reactions | 451W47IQ8X |
| Isolyte S | SODIUM CHLORIDE, SODIUM GLUCONATE, SODIUM ACETATE, POTASSIUM CHLORIDE, AND MAGNESIUM CHLORIDE | B. Braun Medical Inc. | 7e8fe27f-ff82-48c1-9bf6-3c589c8e985d | 2026-10-12 | Warnings, Adverse reactions | 451W47IQ8X |
| Bupivacaine Hydrochloride | BUPIVACAINE HYDROCHLORIDE | Sportpharm LLC | a0f9a86f-fa55-4cbb-8273-5dcecd76d627 | 2026-10-10 | Boxed warning, Warnings, Adverse reactions | 7TQO7W3VT8 |
| Sal De Uvas Picot | CITRIC ACID MONOHYDRATE, SODIUM BICARBONATE | Navajo Manufacturing Company Inc. | ff6ac79d-564d-4abf-83c7-b01751249c7f | 2026-10-09 | Warnings | 2968PHW8QP |
| Sodium Chloride | SODIUM CHLORIDE | CODAN US CORPORATION | aa06e286-75c6-4d7a-959f-6008d38aa6e5 | 2026-10-08 | Warnings, Adverse reactions | 451W47IQ8X |
| GoLYTELY | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE | Braintree Laboratories, Inc. | 57d22b0b-1ae0-4203-babc-f3bac17bd1c9 | 2026-10-08 | Warnings, Adverse reactions | 451W47IQ8X |
| PEG-3350 and Electrolytes | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE | Affordable Pharmaceuticals, LLC | 448db7a5-1fea-4bf3-b1f5-e9d027a36603 | 2026-10-08 | Warnings, Adverse reactions | 451W47IQ8X |
| PEG-3350, sodium chloride, sodium bicarbonate and potassium chloride | POLYETHYLENE GLYCOL 3350, SODIUM CHLORIDE, SODIUM BICARBONATE, POTASSIUM CHLORIDE | Affordable Pharmaceuticals, LLC | 89ca6d56-527a-4be2-baea-531156f0a7be | 2026-10-08 | Warnings, Adverse reactions | 451W47IQ8X |
| Sodium Chloride | SODIUM CHLORIDE | Nextgen Pharmaceuticals LLC | 28f79c75-82d2-4912-81fc-a723b5ccf4c1 | 2026-10-08 | Warnings, Adverse reactions | 451W47IQ8X |
| Sodium Chloride | SODIUM CHLORIDE | SOLA Pharmaceuticals, LLC | 4d0bfd28-460a-48ba-bd17-cf75e56d62f4 | 2026-10-08 | Warnings, Adverse reactions | 451W47IQ8X |
| Lidocaine | LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE | Safco Dental Supply Co | 6721c3ab-c37f-4504-aebc-0103c56ed567 | 2026-10-08 | Warnings, Adverse reactions | 30Q7KI53AK |
| Sodium Chloride | SODIUM CHLORIDE | LABORATORIOS GRIFOLS SA | eb811d79-fdb8-1f1a-c2ad-1cc4bfc7eadf | 2026-10-08 | Warnings, Adverse reactions | 451W47IQ8X |
| Bupivacaine Hydrochloride | BUPIVACAINE HYDROCHLORIDE | Sportpharm LLC | 0e6a55f0-5107-4ea9-9ee1-5c6c09bbe4a6 | 2026-10-06 | Boxed warning, Warnings, Adverse reactions | 7TQO7W3VT8 |
| MEIJER Saline | NASAL | MEIJER | a5c6d800-078a-4b66-9d4c-cf3c53f5c138 | 2026-10-05 | Warnings | 451W47IQ8X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.